Subcutaneous Methotrexate Safe, Effective for Psoriasis

Subcutaneous methotrexate with an intensified 52-week dosing schedule should be considered for patients with psoriasis because of its favorable risk-benefit profile.
Medscape Medical News

http://ift.tt/2iplirX